We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Decellularized Regenerative Device Supports Cardiac Tissues

By HospiMedica International staff writers
Posted on 24 Jun 2019
A novel epicardial patch supports the atria and the ventricular walls of hearts that have been thinned or damaged as a result of myocardial infarct (MI).

The CorMatrix (Rosewell, GA, USA) Cor PATCH is designed to provide host cellular ingrowth and robust angiogenesis in support of adult epicardial structures post MI. More...
It can also be used to treat sequelae secondary to MI that result in a thinning of the left or right ventricular walls, aneurysm formation, or for any other areas requiring a patch. The Cor PATCH is made of a multi-laminate sheet of decellularized lyophilized extracellular matrix (ECM) derived from porcine small intestinal submucosa, which serves as a bioscaffold for vascular ingrowth from adjacent tissues.

The ECM provides a very specific micro-environment. Cells recognize collagen fiber orientation, types of structural proteins, pore size, sequestered paracrine factors, and many other components of the matrix that are specific for each tissue. Progenitor cells and nutrients are delivered by the body to the matrix, which then differentiate into tissue-specific cells and structures. The ECM decellularized material is then naturally degraded and resorbed, gradually replaced by the patient’s own cells, leaving behind the remodeled functional tissue.

“We have a unique opportunity to enhance the repair and recovery of heart muscle after injury using the Cor PATCH technology. This could be a game changer for patients undergoing surgical procedures aimed to increase the blood supply to damaged areas of their heart,” said professor of cardiac surgery Paul Fedak, MD, of the University of Calgary (Alberta, Canada). “My translational research provides an important foundation of data to support the clinical use of this technology as an epicardial patch during coronary bypass surgery. We can now directly target damaged muscle in addition to bypassing blocked vessels.”

The ECM is a collection of extracellular molecules that provides structural and biochemical support to the surrounding cells. It includes the interstitial matrix, composed of polysaccharide gels and fibrous proteins, and the basement membrane, which are sheet-like depositions on which various epithelial cells rest. Each type of connective tissue in animals has a different ECM; collagen fibers and bone mineral comprise the ECM of bone tissue; reticular fibers and ground substance comprise the ECM of loose connective tissue; and blood plasma is the ECM of blood.

Related Links:
CorMatrix


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.